| 000 | 01811 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516162110.0 | ||
| 264 | 0 | _c20150402 | |
| 008 | 201504s 0 0 eng d | ||
| 022 | _a1098-8793 | ||
| 024 | 7 |
_a10.1055/s-0033-1349363 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHoenig, Jonathan | |
| 245 | 0 | 0 |
_aMinimally invasive periorbital rejuvenation. _h[electronic resource] |
| 260 |
_bFacial plastic surgery : FPS _cAug 2013 |
||
| 300 |
_a295-309 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdipose Tissue _xpathology |
| 650 | 0 | 4 |
_aBlepharoplasty _xmethods |
| 650 | 0 | 4 |
_aBlepharoptosis _xetiology |
| 650 | 0 | 4 |
_aBotulinum Toxins, Type A _xadministration & dosage |
| 650 | 0 | 4 |
_aChemexfoliation _xmethods |
| 650 | 0 | 4 |
_aCosmetic Techniques _xadverse effects |
| 650 | 0 | 4 |
_aDiplopia _xetiology |
| 650 | 0 | 4 |
_aEyebrows _xdrug effects |
| 650 | 0 | 4 |
_aEyelids _xdrug effects |
| 650 | 0 | 4 |
_aFacial Muscles _xdrug effects |
| 650 | 0 | 4 | _aForehead |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyaluronic Acid _xadministration & dosage |
| 650 | 0 | 4 | _aInjections, Intradermal |
| 650 | 0 | 4 | _aInjections, Intramuscular |
| 650 | 0 | 4 |
_aKeratolytic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aMedical History Taking |
| 650 | 0 | 4 |
_aMinimally Invasive Surgical Procedures _xmethods |
| 650 | 0 | 4 |
_aNeuromuscular Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aOrbit _xpathology |
| 650 | 0 | 4 | _aPatient Care Planning |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 | _aRejuvenation |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 |
_aSkin Aging _xpathology |
| 650 | 0 | 4 |
_aTretinoin _xtherapeutic use |
| 700 | 1 | _aHoenig, Danya | |
| 773 | 0 |
_tFacial plastic surgery : FPS _gvol. 29 _gno. 4 _gp. 295-309 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-0033-1349363 _zAvailable from publisher's website |
| 999 |
_c22946197 _d22946197 |
||